WO2025160432 - METHODS AND COMPOSITIONS FOR ENHANCING IN VIVO PERSISTENCE AND POTENCY OF CELL THERAPY
National phase entry is expected:
Publication Number
WO/2025/160432
Publication Date
31.07.2025
International Application No.
PCT/US2025/012999
International Filing Date
24.01.2025
Title **
[English]
METHODS AND COMPOSITIONS FOR ENHANCING IN VIVO PERSISTENCE AND POTENCY OF CELL THERAPY
[French]
MÉTHODES ET COMPOSITIONS POUR AMÉLIORER LA PERSISTANCE IN VIVO ET L'EFFICACITÉ D'UNE THÉRAPIE CELLULAIRE
Applicants **
POSEIDA THERAPEUTICS, INC.
SHEDLOCK, Devon
CORONELLA, Julia
COFFEY, Michael
TIMBERLAKE, Nina D.
CONNERNEY, Jeanette
Inventors
SHEDLOCK, Devon
CORONELLA, Julia
COFFEY, Michael
TIMBERLAKE, Nina D.
CONNERNEY, Jeanette
Priority Data
63/625,657
26.01.2024
US
63/698,868
25.09.2024
US
63/734,944
17.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3250 | |
| EPO | Filing, Examination, Granting | 20279 | |
| Japan | Filing, Examination, Granting | 2797 | |
| South Korea | Filing, Examination, Granting | 3197 | |
| USA | Filing, Examination, Granting | 7990 |
Total:
37,513
Abstract[English]
The present disclosure relates to methods and compositions for increasing the in vivo persistence and potency of cell therapies including the administration of CAR cells in a subject.[French]
La présente divulgation concerne des méthodes et des compositions pour augmenter la persistance in vivo et l'efficacité de thérapies cellulaires comprenant l'administration de cellules CAR à un sujet.